NCR Partners Solo Health - Analyst Blog

By Zacks Equity Research,

Shutterstock photo

NCR Corporation ( NCR ) recently announced a technical collaboration with SoloHealth, wherein NCR will install upgraded self-service healthcare kiosks across the U.S. These kiosks offer shoppers across the country easy access to health assessment procedures. NCR will also provide technical assistance to all the installed kiosks according to the terms of the agreement.

NCR has been consistently increasing its national footprint and enhancing its service quality. Through this collaboration, NCR technology will reach 2,500 retail locations, to which it is expected to help drive traffic.

The demand for self-service kiosks has increased considerably, as evident from the company's recorded consumer interaction of above 3.2 million at the existing kiosks as of mid-October. Quality time has been spent by users in these kiosks and it has been seen that around 33% of users take more tests in these kiosks.

Healthcare is a comparatively new area of activity for NCR, as the company will be providing a cloud-based healthcare consumer platform, which is a new area of activity for NCR.

We remain highly positive about NCR's position in the ATM and Point-of-Sale solutions (POS) segments. Moreover, as per the data collected by RBR from different banks and other deployers, the firm has made a "Global ATM Market and Forecast to 2013," which confirms NCR as the largest ATM manufacturer in the world with an installed base market share of 30.1%. RBR is also of the opinion that NCR holds a leadership position in China and North America, with an installed base market share of 32.0% and 26.4%, respectively.

We remain highly positive about NCR's broad exposure in the ATM space. However, the market is not without competition, which comes in the form Diebold Inc. ( DBD ) and Wincor Nixdorf to name a few.

Currently, NCR has a Zacks #3 Rank (short-term Hold rating).

DIEBOLD INC (DBD): Free Stock Analysis Report

NCR CORP-NEW (NCR): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Business , Stocks
Referenced Stocks: DBD , NCR

More from


Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by